Rinopanteina Gocce
by Drugs Minerals and Generics Italia S.r.l. 5 variants
Ref 80RIN006MModel Gocce Nasali
Active
CE MDR
Valid until
11 Apr 2029
FDA recalls
Not applicable
Documents
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/MDR | Number803412518TF046S 08034125186396 | Date7 May 2026 | StatusActive |
Certificates
- EPT 0477.MDR.24/5445 Active
Quality management system EU MDR
- Certifier
- Eurofins Product Testing Italy S.r.l. 0477
- Issued
- 12 Apr 2024
- Expires
- 11 Apr 2029
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
European Union — CE/MDR Active
Specification
- Model / Reference
- Gocce Nasali, 80RIN006M
- Primary DI / UDI-DI
- 08034125186396
- Basic UDI-DI
- 803412518TF046S
- EMDN Code
- M9099 General and specialist medical devices – other (suture patches see h900102)
- Device Class
- Class IIa
- EU market of registration
- Italy
Manufacturer details
- EUDAMED SRN
- IT-MF-000024945
Other devices from Drugs Minerals and Generics Italia S.r.l.
See all devices from Drugs Minerals and Generics Italia S.r.l. →
Properties
Other properties (13)
- Sterile: No
- Implantable: No
- Reusable: No
- Contains Latex: No
- Reprocessed: No
- CMR Substance: No
- Human-derived: No
- Human Tissues: No
- Animal Tissues: No
- Endocrine Disruptor: No
- Administering Medicine: No
- Measuring Function: No
- Incorporates Medicinal Product: No